Thrombospondin-1 is a multifaceted player in tumor progression
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
// Tingting Huang 1 , Li Sun 1 , Xianglin Yuan 1 and Hong Qiu 1 1 Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China Correspondence to: Hong Qiu, email: tjqiuhong@163.com Keywords: thrombospondin-1, tumor progression, tumor angiogenesis, cancer cell behavior, tumor immunity Received: March 16, 2017 Accepted: June 28, 2017 Published: July 11, 2017 ABSTRACT Thrombospondins are a family of extracellular matrix (ECM) proteins. Thrombospondin-1 (TSP1) was the first member to be identified and is a main player in tumor microenvironment. The diverse functions of TSP1 depend on the interactions between its structural domains and multiple cell surface molecules. TSP1 acts as an angiogenesis inhibitor by stimulating endothelial cell apoptosis, inhibiting endothelial cell migration and proliferation, and regulating vascular endothelial growth factor bioavailability and activity. In addition to angiogenesis modulation, TSP1 also affects tumor cell adhesion, invasion, migration, proliferation, apoptosis and tumor immunity. This review discusses the multifaceted and sometimes opposite effects of TSP1 on tumor progression depending on the molecular and cellular composition of the microenvironment. Clinical implications of TSP1-related compounds are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423 · cited 1×
“Loss of TSP1 expression was regarded as an “angiogenic switch” from the non-angiogenic phenotype in tumor progression [3].”
BackgroundMiller, T. W., Kaur, S., Ivins-O'Keefe, K., & Roberts, D. D. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.02.009 · Cited by 109
Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis
Lopez-Dee, Z. P., Chittur, S. V., Patel, H., Chinikaylo, A., Lippert, B., Patel, B., Lawler, J., & Gutierrez, L. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139918 · Cited by 23
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Self-citationPhosphorylated ATF1 at Thr184 promotes metastasis and regulates MMP2 expression in gastric cancer
Li, T., Cao, H., Wu, S., Zhong, P., Ding, J., Wang, J., Wang, F., He, Z., & Huang, G.-L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03361-3 · Cited by 16
Metadata
- Authors
- Huang, T., Sun, L., Yuan, X., & Qiu, H.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-07-11
- Volume
- 8
- Issue
- 48
- Pages
- 84546-84558
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2734979627
- Cited by
- 158
- References
- 3
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thrombospondin-1 is a multifaceted player in tumor progression. https://app.cochat.ai/papers/10.18632/oncotarget.19165
- The paper
- Huang, T., Sun, L., Yuan, X., & Qiu, H. (2017). Thrombospondin-1 is a multifaceted player in tumor progression. Oncotarget. https://doi.org/10.18632/oncotarget.19165
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.